Voices
Endometrial Cancer

Panel Discussion on Endometrial Cancer Challenges and Advances – FDA Oncology

FDA Oncology shared a post on X:

“69K Americans will face an endometrial cancer diagnosis this year. 14K won’t survive. FDA panel discussion will hear from patients/advocates about treatment gaps. “Endometrial Cancer: Rising Incidence, Rising Innovation” Sept 18.”

More from FDA Oncology on OncoDaily.

cancer Endometrial cancer FDA FDA Oncology OncoDaily Oncology